Roivant Sciences Ltd.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $527.7M | $2.59B | $2.06B |
| FY2022 | $523.7M | $2.59B | $2.06B |
| FY2023 | $782.0M | $2.39B | $1.68B |
| FY2024 | $774.0M | $7.22B | $6.49B |
| FY2025 | $249.7M | $5.44B | $2.72B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $527.7M | $2.59B | $2.06B |
| FY2022 | $523.7M | $2.59B | $2.06B |
| FY2023 | $782.0M | $2.39B | $1.68B |
| FY2024 | $774.0M | $7.22B | $6.49B |
| FY2025 | $249.7M | $5.44B | $2.72B |